Yield10 Bioscience Stock Price, News & Analysis (NASDAQ:YTEN)

$3.58 -0.74 (-17.13 %)
(As of 12/15/2017 05:13 AM ET)
Previous Close$4.32
Today's Range$3.38 - $4.40
52-Week Range$1.82 - $9.30
Volume505,600 shs
Average Volume75,171 shs
Market Capitalization$14.54 million
P/E RatioN/A
Dividend YieldN/A
Beta3.42

About Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience logoYield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.

Receive YTEN News and Ratings via Email

Sign-up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:YTEN
CUSIPN/A
Phone617-583-1700

Debt

Debt-to-Equity Ratio0.41%
Current Ratio1.76%
Quick Ratio1.76%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.16 million
Price / Sales10.68
Cash FlowN/A
Price / CashN/A
Book Value$2.24 per share
Price / Book1.60

Profitability

Trailing EPS($2.95)
Net Income$-7,600,000.00
Net Margins-743.10%
Return on Equity-214.42%
Return on Assets-109.09%

Miscellaneous

Employees20
Outstanding Shares3,460,000

Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions

What is Yield10 Bioscience's stock symbol?

Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."

When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work?

Yield10 Bioscience's stock reverse split on Tuesday, May 30th 2017. The 1-10 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 26th 2017. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 10 shares after the split.

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience Inc (NASDAQ:YTEN) released its quarterly earnings data on Thursday, November, 9th. The specialty chemicals company reported ($0.59) earnings per share (EPS) for the quarter. The specialty chemicals company earned $0.22 million during the quarter. Yield10 Bioscience had a negative return on equity of 214.42% and a negative net margin of 743.10%. View Yield10 Bioscience's Earnings History.

Who are some of Yield10 Bioscience's key competitors?

Who are Yield10 Bioscience's key executives?

Yield10 Bioscience's management team includes the folowing people:

  • Robert L. Van Nostrand, Chairman of the Board, Independent Director (Age 60)
  • Oliver P. Peoples Ph.D., President, Chief Executive Officer, Director (Age 58)
  • Charles B. Haaser, Chief Accounting Officer, Vice President - Finance (Age 60)
  • Lynne H. Brum, Vice President - Planning and Communications (Age 52)
  • Kristi Snell Ph.D., Chief Science Officer, Vice President - Research
  • Sarah P. Cecil, General Counsel, Secretary (Age 64)
  • Richard William Hamilton Ph.D., Director (Age 54)
  • Joseph H. Shaulson, Director (Age 50)
  • Peter N. Kellogg, Independent Director (Age 61)
  • Anthony J. Sinskey Sc.D, Independent Director (Age 76)

Who owns Yield10 Bioscience stock?

Yield10 Bioscience's stock is owned by many different of retail and institutional investors. Top institutional investors include GMT Capital Corp (0.97%). View Institutional Ownership Trends for Yield10 Bioscience.

Who bought Yield10 Bioscience stock? Who is buying Yield10 Bioscience stock?

Yield10 Bioscience's stock was purchased by a variety of institutional investors in the last quarter, including GMT Capital Corp. View Insider Buying and Selling for Yield10 Bioscience.

How do I buy Yield10 Bioscience stock?

Shares of Yield10 Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Yield10 Bioscience's stock price today?

One share of Yield10 Bioscience stock can currently be purchased for approximately $3.58.

How big of a company is Yield10 Bioscience?

Yield10 Bioscience has a market capitalization of $14.54 million and generates $1.16 million in revenue each year. The specialty chemicals company earns $-7,600,000.00 in net income (profit) each year or ($2.95) on an earnings per share basis. Yield10 Bioscience employs 20 workers across the globe.

How can I contact Yield10 Bioscience?

Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at 617-583-1700 or via email at [email protected]


MarketBeat Community Rating for Yield10 Bioscience (YTEN)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  155
MarketBeat's community ratings are surveys of what our community members think about Yield10 Bioscience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Yield10 Bioscience (NASDAQ:YTEN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/ABuy
Consensus Rating Score: N/AN/AN/A3.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/A$30.00
Price Target Upside: N/AN/AN/A2,207.69% upside

Yield10 Bioscience (NASDAQ:YTEN) Consensus Price Target History

Price Target History for Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience (NASDAQ:YTEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2016HC WainwrightReiterated RatingBuyN/AView Rating Details
2/9/2016Rodman & RenshawInitiated CoverageBuy$30.00N/AView Rating Details
(Data available from 12/15/2015 forward)

Earnings

Yield10 Bioscience (NASDAQ:YTEN) Earnings History and Estimates Chart

Earnings by Quarter for Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience (NASDAQ YTEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.59)$0.22 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.96)$0.29 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.70)$0.32 millionViewN/AView Earnings Details
11/9/2016Q116($1.40)($0.50)$0.47 millionViewListenView Earnings Details
5/16/2016Q1($2.30)($2.40)$0.89 million$0.68 millionViewN/AView Earnings Details
3/29/2016Q415($2.40)($2.20)$0.92 million$0.50 millionViewListenView Earnings Details
11/10/2015Q315($2.60)($2.20)$0.71 millionViewListenView Earnings Details
8/12/2015Q215($2.60)$0.74 millionViewListenView Earnings Details
5/13/2015Q115($0.40)($0.40)$0.65 millionViewListenView Earnings Details
3/19/2015Q414($0.90)($0.50)$0.86 millionViewListenView Earnings Details
11/5/2014Q3 14($1.60)($1.40)$1.10 million$0.63 millionViewListenView Earnings Details
8/6/2014($2.30)($2.10)$1.40 million$1.17 millionViewN/AView Earnings Details
5/14/2014($2.10)($2.30)$1.25 million$1.07 millionViewN/AView Earnings Details
3/27/2014($2.10)($2.50)ViewN/AView Earnings Details
11/5/2013Q3 13($2.40)($2.10)ViewN/AView Earnings Details
7/31/2013Q2 2013($2.00)($2.30)$1.57 millionViewN/AView Earnings Details
5/8/2013Q1 2013($2.50)($2.00)$1.43 million$1.94 millionViewN/AView Earnings Details
3/26/2013Q4 2012($2.60)($2.80)$1.23 million$1.40 millionViewN/AView Earnings Details
11/1/2012($2.40)($2.30)ViewN/AView Earnings Details
7/26/2012($2.60)($2.30)ViewN/AView Earnings Details
4/26/2012$8.40$8.40ViewN/AView Earnings Details
3/6/2012($3.00)($2.80)ViewN/AView Earnings Details
11/1/2011($2.90)($2.80)ViewN/AView Earnings Details
7/27/2011($3.30)($3.30)ViewN/AView Earnings Details
4/27/2011($3.60)($3.60)ViewN/AView Earnings Details
3/9/2011($3.70)($3.50)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Yield10 Bioscience (NASDAQ:YTEN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Yield10 Bioscience (NASDAQ:YTEN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Yield10 Bioscience (NASDAQ YTEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 11.20%
Institutional Ownership Percentage: 10.67%
Insider Trades by Quarter for Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience (NASDAQ YTEN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2016William P ScullyMajor ShareholderSell68,333$0.33$22,549.89View SEC Filing  
9/9/2016William P ScullyMajor ShareholderSell165,000$0.35$57,750.00View SEC Filing  
9/17/2015William P ScullyMajor ShareholderBuy31,833$2.11$67,167.63View SEC Filing  
9/15/2015William P. Scullymajor shareholderBuy67,500$2.16$145,800.00View SEC Filing  
9/10/2015William P ScullyMajor ShareholderBuy25,000$2.71$67,750.00View SEC Filing  
9/8/2015William P ScullyMajor ShareholderBuy40,000$2.23$89,200.00View SEC Filing  
9/4/2015William P. Scullymajor shareholderBuy42,750$2.15$91,912.50View SEC Filing  
8/28/2015William P ScullyMajor ShareholderBuy26,600$1.99$52,934.00View SEC Filing  
6/19/2015Birchview Capital Gp, LlcDirectorBuy43,700$3.32$145,084.00View SEC Filing  
6/19/2015Family Foundation SchulerMajor ShareholderBuy1,664,840$3.32$5,527,268.80View SEC Filing  
6/19/2015Joseph H ShaulsonCEOBuy35,000$3.32$116,200.00View SEC Filing  
6/19/2015Lynne H BrumVPBuy14,570$3.32$48,372.40View SEC Filing  
6/19/2015Walsem Johan VanCOOBuy12,000$3.32$39,840.00View SEC Filing  
11/29/2013Matthew StrobeckDirectorBuy100,000$1.00$100,000.00View SEC Filing  
12/3/2012Richard P EnoCEOBuy20,000$1.17$23,400.00View SEC Filing  
11/30/2012Nostrand Robert L VanDirectorBuy20,000$1.07$21,400.00View SEC Filing  
11/30/2012Oliver P PeoplesVPBuy40,000$1.07$42,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Yield10 Bioscience (NASDAQ YTEN) News Headlines

Source:
DateHeadline
Yield10 Bioscience Soars on Monsanto License Deal, Technology Review and Market HighlightsYield10 Bioscience Soars on Monsanto License Deal, Technology Review and Market Highlights
finance.yahoo.com - December 12 at 10:57 AM
UPDATE: Yield10 Bioscience, Inc. (YTEN) Climbs 200% After Granting Research License to MonsantoUPDATE: Yield10 Bioscience, Inc. (YTEN) Climbs 200% After Granting Research License to Monsanto
www.streetinsider.com - December 11 at 4:35 PM
Here’s Why Yield10 Bioscience Inc (YTEN) Shares Are Jumping Like a BeanstalkHere’s Why Yield10 Bioscience Inc (YTEN) Shares Are Jumping Like a Beanstalk
finance.yahoo.com - December 11 at 4:35 PM
Reviewing Yield10 Bioscience (YTEN) & PAREXEL International (PRXL)Reviewing Yield10 Bioscience (YTEN) & PAREXEL International (PRXL)
www.americanbankingnews.com - December 11 at 11:24 AM
Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017
finance.yahoo.com - December 7 at 10:54 AM
Yield10 Bioscience, Inc. :YTEN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Yield10 Bioscience, Inc. :YTEN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 10:37 AM
Yield10 Bioscience Announces Adjournment of Special Meeting of StockholdersYield10 Bioscience Announces Adjournment of Special Meeting of Stockholders
finance.yahoo.com - November 29 at 10:37 AM
Contrasting Metabolix (YTEN) & Its PeersContrasting Metabolix (YTEN) & Its Peers
www.americanbankingnews.com - November 25 at 7:12 PM
Are You Backing The Right Horse With Yield10 Bioscience Inc (YTEN)?Are You Backing The Right Horse With Yield10 Bioscience Inc (YTEN)?
finance.yahoo.com - November 16 at 10:11 AM
Yield10 Bioscience Announces Third Quarter 2017 Financial ResultsYield10 Bioscience Announces Third Quarter 2017 Financial Results
finance.yahoo.com - November 12 at 1:43 PM
Metabolix, Inc. (YTEN) Posts  Earnings ResultsMetabolix, Inc. (YTEN) Posts Earnings Results
www.americanbankingnews.com - November 10 at 2:34 PM
Comparing Metabolix (YTEN) & Celldex Therapeutics (CLDX)Comparing Metabolix (YTEN) & Celldex Therapeutics (CLDX)
www.americanbankingnews.com - November 8 at 5:28 AM
Yield10 Bioscience to Host Webcast of its Third Quarter 2017 Conference CallYield10 Bioscience to Host Webcast of its Third Quarter 2017 Conference Call
finance.yahoo.com - November 6 at 9:48 AM
Metabolix (YTEN) versus Its Peers Financial ContrastMetabolix (YTEN) versus Its Peers Financial Contrast
www.americanbankingnews.com - November 5 at 5:26 AM
Reviewing Metabolix (YTEN) & ImmunoGen (IMGN)Reviewing Metabolix (YTEN) & ImmunoGen (IMGN)
www.americanbankingnews.com - November 3 at 1:10 AM
Who Are The Largest Shareholders In Yield10 Bioscience Inc (YTEN)?Who Are The Largest Shareholders In Yield10 Bioscience Inc (YTEN)?
finance.yahoo.com - November 2 at 11:54 AM
Yield10 Bioscience, Inc. :YTEN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017Yield10 Bioscience, Inc. :YTEN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
finance.yahoo.com - October 4 at 1:28 PM
Yield10 Bioscience to Participate in U.S. Department of Energy Grant for Boosting Oilseed Yield in CamelinaYield10 Bioscience to Participate in U.S. Department of Energy Grant for Boosting Oilseed Yield in Camelina
finance.yahoo.com - September 15 at 11:57 AM
Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina LineYield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line
www.nasdaq.com - September 5 at 3:34 PM
Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina LineYield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line
finance.yahoo.com - September 5 at 3:34 PM
Metabolix, Inc. (NASDAQ:YTEN) Releases Quarterly  Earnings ResultsMetabolix, Inc. (NASDAQ:YTEN) Releases Quarterly Earnings Results
www.americanbankingnews.com - August 11 at 11:50 AM
Yield10 Bioscience Announces Second Quarter 2017 Financial ResultsYield10 Bioscience Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 11 at 9:21 AM
Yield10 Bioscience Announces Collaboration with National Research Council of Canada to Improve Yield and Drought Tolerance in WheatYield10 Bioscience Announces Collaboration with National Research Council of Canada to Improve Yield and Drought Tolerance in Wheat
finance.yahoo.com - August 9 at 9:31 AM
Yield10 Bioscience to Host Webcast of its Second Quarter 2017 Conference CallYield10 Bioscience to Host Webcast of its Second Quarter 2017 Conference Call
finance.yahoo.com - July 27 at 9:49 AM
Yield10 Bioscience Announces Pricing of $2.3 Million Registered Direct OfferingYield10 Bioscience Announces Pricing of $2.3 Million Registered Direct Offering
finance.yahoo.com - July 3 at 8:43 AM
Yield10 Bioscience Starts Field Tests of Novel Yield Trait Gene C3003 in Oilseed Crops Camelina and CanolaYield10 Bioscience Starts Field Tests of Novel Yield Trait Gene C3003 in Oilseed Crops Camelina and Canola
globenewswire.com - June 9 at 2:56 AM
Yield10 Bioscience, Inc. 2017 Q1 - Results - Earnings Call SlidesYield10 Bioscience, Inc. 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 12 at 3:20 PM
YIELD10 BIOSCIENCE, INC. Files SEC form 10-K, Annual ReportYIELD10 BIOSCIENCE, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 8:39 PM
YIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andYIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
biz.yahoo.com - March 23 at 9:03 AM
YIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsYIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - January 27 at 6:56 AM
YIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal OfficersYIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - January 17 at 12:07 PM

SEC Filings

Yield10 Bioscience (NASDAQ:YTEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Yield10 Bioscience (NASDAQ:YTEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Yield10 Bioscience (NASDAQ YTEN) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.